22 §2698-A. Marketing costs (REPEALED)
§2698-A. Marketing costs (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 688, §C8 (AMD). PL 2005, c. 286, §§1,2 (AMD). PL 2011, c. 461, §3 (RP).
22 §2698-B. Actual price disclosure and certification (REPEALED)
§2698-B. Actual price disclosure and certification (REPEALED) SECTION HISTORY PL 2003, c. 667, §1 (NEW). PL 2003, c. 667, §2 (AFF). PL 2005, c. 402, §§1-4 (AMD). PL 2011, c. 461, §4 (RP).
22 §2699. Prescription drug practices (REPEALED)
§2699. Prescription drug practices (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 430, §1 (NEW). PL 2003, c. 430, §3 (AFF). PL 2003, c. 456, §1 (NEW). PL 2003, c. 673, §§FFF1,2 (AMD). PL 2003, c. 688, §§C9,10 (AMD). PL 2003, c. 688, §C11 (AFF). […]
22 §2692. Prescription Drug Advisory Commission (REPEALED)
§2692. Prescription Drug Advisory Commission (REPEALED) SECTION HISTORY PL 1999, c. 786, §A3 (NEW). PL 2007, c. 395, §25 (RP).
22 §2693. Emergency drug pricing
§2693. Emergency drug pricing In order to achieve the public health purposes listed in section 2691, maximum retail prices for prescription drugs sold in Maine may be established pursuant to this section. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Emergency drug pricing procedures. The following provisions apply to determinations regarding maximum retail […]
22 §2694. Rulemaking
§2694. Rulemaking With the exception of rules designated in this subchapter as major substantive rules, rules adopted pursuant to this subchapter are routine technical rules as defined by Title 5, chapter 375, subchapter II‑A. [PL 1999, c. 786, Pt. A, §3 (NEW).] SECTION HISTORY PL 1999, c. 786, §A3 (NEW).
22 §2697. Profiteering in prescription drugs
§2697. Profiteering in prescription drugs Prescription drugs are a necessity of life. Profiteering in prescription drugs is unlawful and is subject to the provisions of this section. The provisions of this section apply to manufacturers, distributors and labelers of prescription drugs. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Definitions. As used in […]
22 §2698. Investigation by Attorney General
§2698. Investigation by Attorney General The Attorney General, upon the Attorney General’s own initiative or upon petition of the commissioner or of 50 or more residents of the State, shall investigate suspected violations of this subchapter. [PL 1999, c. 786, Pt. A, §3 (NEW).] The Attorney General may require, by summons, the attendance and […]
22 §2681. Maine Rx Plus Program established
§2681. Maine Rx Plus Program established The Maine Rx Plus Program, referred to in this subchapter as the “program,” is established to reduce prescription drug prices and to improve the quality of health care for residents of the State. The program is administered by the department and must utilize manufacturer rebates and pharmacy discounts to […]
22 §2682. Display of Maine Rx Plus Program participation information
§2682. Display of Maine Rx Plus Program participation information A drug dispensed pursuant to prescription, including a drug dispensed without charge to the consumer, must be accompanied by program participation information in a manner approved by the commissioner and as permitted by law. [PL 2001, c. 471, Pt. E, §5 (AMD); PL 2001, c. […]